Foresite Capital Management Iv, LLC Ngm Biopharmaceuticals Inc Transaction History

Foresite Capital Management Iv, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 13, 2019	SELL	$13.09 - $18.19 $6.17 Million - $8.57 Million	-471,269 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$12.56 - $16.6 $5.92 Million - $7.82 Million	471,269 New	471,269 $6.9 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.